Use of topiramate in localization-related epilepsy in children

Journal of Child Neurology

Volumn 15, Issue SUPPL. 1, 2000, Pages

  Holland, K D ^a   Wyllie, E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; LIVER TOXICITY; NEPHROLITHIASIS; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SIDE EFFECT; WEIGHT REDUCTION;

EID: 0034469916     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073800015001s02     Document Type: Article

References (28)

1. Effects of topiramate on sustained repetitive firing and spontaneous recurrent discharges in cultured hippocampal neurons
2. Topiramate modulates GABA-evoked currents in murine cortical neurons by a non-benzodiazepine mechanism
3. Cellular actions of topiramate blockade of kainate-evoked inward currents in cultured hippocampal neurons
4. Topiramate as an inhibitor of carbonic anhydrase isoenzymes
5. Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs
6. Drug interaction profile of topiramate
7. Topiramate: A review of preclinical, pharmacokinetic, and clinical data
8. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, 600-mg daily dosages
9. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, 1000-mg daily dosages
10. Double-blind, placebo-controlled trial of topiramate (600 mg daily) as add-on therapy in patients with refractory partial epilepsy
11. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
12. Double-blind placebo-controlled trial of topiramate as add-on therapy for the treatment of partial seizures
13. Topiramate monotherapy for partial onset seizures
14. Long term experience with topiramate as adjunctive therapy and as monotherapy for partial-onset seizures: Retrospective survey of open-label treatment
15. A double-blind, randomized trial for topiramate as adjunctive therapy for partial-onset seizures in children
16. Effectiveness, tolerability and safety of topiramate in children with partial-onset seizures
17. A study of topiramate pharmacokinetics and tolerability in children with epilepsy
18. Topiramate pharmacokinetics in infancy
19. Topiramate for intractable childhood epilepsy
20. Topiramate in intractable childhood onset epilepsy-A cautionary note
21. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate
22. Topiramate efficacy in infancy
23. New antiepileptic drugs: A systematic review of their efficacy and tolerability
24. New antiepileptic drugs. Analysis based on number needed to treat shows differences between drugs studied
25. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults
26. A multicenter randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures
27. Topiramate in Lennox-Gastaut syndrome: Open-label treatment of patients completing a randomized trial
28. Long-term response to topiramate in patients with West syndrome: Open-label treatment of patients completing a randomized trial